News

Innocan Pharma Celebrates Dr. Pergolizzi's Global Recognition

Innocan Pharma Celebrates Dr. Pergolizzi's Global Recognition

Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Achievement

Innocan Pharma Corporation has recently acknowledged Dr. Joseph V. Pergolizzi, Jr. for being recognized as one of the top 2% most-cited scientists in the world according to a new list from Stanford University. This remarkable achievement highlights Dr. Pergolizzi's significant contributions to medical science and emphasizes his influential role in advancing healthcare practices globally.

Dr. Pergolizzi's Role at Innocan Pharma

Appointed to Innocan Pharma's Scientific Advisory Board, Dr. Pergolizzi focuses on enhancing drug development and supporting the company’s initiatives for FDA filing on new medications. His extensive experience in pain management and critical care medicine is invaluable as Innocan navigates the complexities of pharmaceutical advancements.

CEO's Praise for Dr. Pergolizzi

Iris Bincovich, CEO of Innocan Pharma, expressed immense pride in Dr. Pergolizzi's recognition. She emphasized his influential work in medical research, which has significantly contributed to Innocan's research and development goals. Dr. Pergolizzi’s expertise has been crucial in aligning the company's strategies with FDA regulatory standards, facilitating innovative therapies aimed at improving patients' quality of life.

Innovative Segments of Innocan Pharma

Innocan Pharma operates through two key segments, Pharmaceuticals and Consumer Wellness. The Pharmaceuticals branch is dedicated to creating advanced drug delivery platforms utilizing cannabinoids to treat diverse medical conditions, enhancing the overall well-being of patients.

Pharmaceuticals Segment Focus

The pharmaceuticals segment features innovative technologies, including the LPT CBD-loaded liposome platform. This platform provides precise dosing and regulates the release of CBD into the bloodstream, with ongoing preclinical trials for epilepsy and pain management.

Consumer Wellness Initiatives

Innocan’s Consumer Wellness segment is dedicated to producing high-performance self-care products that promote healthier lifestyles. The company has also formed a joint venture named BI Sky Global Ltd. to enhance targeted online sales, further solidifying its market presence.

Contacting Innocan Pharma

For information regarding Innocan Pharma Corporation, interested parties can reach out to:

Iris Bincovich, CEO
+1 5162104025
+972-54-3012842
+442037699377
Email: info@innocanpharma.com

Frequently Asked Questions

What recognition did Dr. Joseph Pergolizzi receive?

Dr. Pergolizzi was recognized among the top 2% most-cited scientists worldwide by Stanford University.

What is the main focus of Innocan Pharma?

Innocan Pharma focuses on developing innovative drug delivery platforms and self-care wellness products.

How does Dr. Pergolizzi contribute to Innocan Pharma?

He contributes by guiding the company’s pharmaceutical R&D and assisting with FDA submissions.

What are Innocan's key segments?

The key segments of Innocan are Pharmaceuticals and Consumer Wellness, targeting innovative therapies and wellness products.

How can people contact Innocan Pharma?

People can contact Innocan Pharma via email or phone as provided in the contact information section.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 6

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 7

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 7

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 12

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Endeavour Mining's Latest Share Transactions and Operations

Updated Category News Views 340

Endeavour Mining's Recent Share Transactions Endeavour Mining plc has made significant strides in its operations in the recent past, with notable transactions involving the purchase of its own shares. This initiative is part of their strategy to enhance shareholder value and reflect their continued commitment to sustainable growth in the mining sector. Understanding the...

Continue Reading
GemPharmatech Inaugurates Cutting-Edge Biotech Hub in the U.S.

Updated Category News Views 171

GemPharmatech's New Facility: A Milestone in Biotech GemPharmatech has significantly enhanced its U.S. capabilities with the unveiling of a transformative new facility in San Diego. With an emphasis on supporting preclinical research, this advanced laboratory and rodent vivarium is set to serve the booming North American biomedical research and pharmaceutical development...

Continue Reading
Manulife's CFO Colin Simpson to Engage in Insightful Discussion

Updated Category News Views 154

Manulife's CFO Colin Simpson to Engage in Insightful Discussion Manulife Financial Corporation (TSX/NYSE/PSE: MFC; SEHK: 945) is delighted to announce that Colin Simpson, the company's Chief Financial Officer, will be participating in a professional fireside chat session at the esteemed Desjardins Toronto Conference. This event is set to take place on an upcoming Tuesday,...

Continue Reading
Celestica's Upcoming Financial Results and Investor Day Preview

Updated Category News Views 370

Celestica's Announcement for Q3 2025 Financial Results Celestica Inc. (TSX and NYSE: CLS) is gearing up for its third quarter 2025 financial results conference call and an exciting Investor and Analyst Day. The scheduled call will take place on a Tuesday morning soon after the market closes, providing valuable insights to participants. Conference Call Details The...

Continue Reading
Exciting Sports Betting Launch in Missouri Set for December

Updated Category News Views 126

Missouri's Sports Betting Launch: What You Need to Know Lineups, a premier destination for sports betting analysis and operator insights, has exciting news for sports enthusiasts! Come December, Missouri will officially kick off its sports betting operations, allowing residents to indulge in their favorite pastime legally. This major development promises not only an array...

Continue Reading